Earnings call Year-end report 2023
On February 9, Alligator held its earnings call which was streamed live to our Youtube-channel.
CEO Søren Bregenholt, CFO Marie Svensson and CMO Sumeet Ambarkhane presented the report, which was followed by a Q&A chat session.
KOL webinar
On January 29th, Alligator held a KOL webinar where Prof. Zev Wainberg discussed the top-line data from the OPTIMIZE-1 study with mitazalimab.
The formal presentation was followed by a chat Q&A together with Alligator’s CEO Søren Bregenholt and CMO Sumeet Ambarkhane.
Follow this link to access the webinar.
LATEST NEWS
Alligator Bioscience publishes prospectus in connection with forthcoming rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, …
Bulletin from the extraordinary general meeting in Alligator Bioscience AB
Today, on 14 March 2024, an extraordinary general meeting was held in Alligator Bioscience AB. A summary of the adopted resolutions follows …
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4
Initial interim data show favorable drug exposure and confirm ALG.APV-527 biological activity Early promising signs of clinical activity in …